|
|
|
Innovative Cancer Therapy Approaches
Hiroshi Maruta
Hiroshi Maruta
ISBN: 9780124762497
Format: Hardback
Publisher:Elsevier Science & Technology
Write a review
There has been increased focus on alternative treatments for cancer. This text presents the various cancer therapeutics that are being used or developed as a result of our knowledge about oncogenes, tumour suppressor genes and viral and non-viral replication.
Tumor Suppressing Viruses, Genes, and Drugs profiles the new generation of cancer treatments now in development. The book examines the innovative new approaches of viral, gene, and signal therapies that promise to replace or enhance conventional methods such as surgery, radiation, and chemotherapy. The timely information presented by this book should be of interest to anyone concerned with advancing cancer treatment beyond current medical practices.
| ISBN | 0124762492 | | DEWEY edition | DC21 | | ISBN13 | 9780124762497
(What's this?) | | Pages | 425 | | Publisher | Elsevier Science & Technology | | Volumes | 1 | | Imprint | Academic Press Inc | | Weight (grammes) | 730 | | Format | Hardback | | Published in | Oxford | | Publication date | 03 Dec 2001 | | Height (mm) | 229 | | Non-book description | xv, 425 p. : | | Width (mm) | 152 | | Library of Congress | RC268.43.T | | Spine width (mm) | 23 | | DEWEY | 616.99406 | | Academic level | Professional / Scholarly |
|
| |
| | | Contributors | | | | | | Preface | | | | 1 | | Oncolytic Viruses: Virotherapy for Cancer by Lynda K. Hawkins and David Kirn | | 1 | | 2 | | Reovirus Therapy of Ras-Associated Cancers by Patrick W. K. Lee | | 31 | | 3 | | Oncolytic Herpes Simplex Virus (G207) Therapy: From Basic to Clinical by Tomoki Todo and Michael I. Ebright and Yuman Fong | | 45 | | 4 | | p53 and Its Targets by Rishu Takimoto and Wafik S. El-Deiry | | 77 | | 5 | | Prospects for Tumor Suppressor Gene Therapy: RB as an Example by Daniel J. Riley and Wen-Hwa Lee | | 97 | | 6 | | CDK Inhibitors: Genes and Drugs by Jun-ya Kato and Kiichiro Tomoda and Yukinobu Arata | | 123 | | 7 | | CDK Inhibitors: Small Molecular Weight Compounds by Laurent Meijer and Eve Damiens | | 145 | | 8 | | NF1 and Other RAS-Binding Peptides by Hiroshi Maruta | | 169 | | 9 | | Cytoskeletal Tumor Suppressor Genes by Noboru Kuzumaki and Hiroshi Maruta | | 177 | | 10 | | TGF-[beta] Signaling and Carcinogenesis by Masahiro Kawabata | | 199 | | 11 | | DAN Gene by Shigeru Sakiyama | | 221 | | 12 | | Design of Hammerhead Ribozymes and Allosterically Controllable Maxizymes for Cancer Gene Therapy by Hiroaki Kawasaki and Tomoko Kuwabara and Kazunari Taira | | 233 | | 13 | | Inhibitors of Angiogenesis by Steven A. Stacker and Marc G. Achen | | 261 | | 14 | | Geranylgeranylated RhoB Mediates the Apoptotic and Antineoplastic Effects of Farnesyltransferase Inbitors: New Insights into Cancer Cell Suicide by George C. Prendergast | | 293 | | 15 | | RAS Binding Compounds by Oliver Muller and Alfred Wittinghofer | | 311 | | 16 | | Actin-Binding Drugs: MKT-077 and Chaetoglobosin K(CK) by Hiroshi Maruta | | 329 | | 17 | | Tyr Kinase Inhibitors as Potential Anticancer Agents: EGF Receptor and ABL Kinases by Antony W. Burgess | | 341 | | | More... | | |
"...a brave attempt to encompass a broad, exciting and developing field." -MICROBIOLOGY TODAY (2003)  Be the first to write a customer review
|
|
|
|
|
Enlarge
